Oxidant stress as a marker for cardiovascular events: Ox marks the spot

Circulation

Volumn 104, Issue 22, 2001, Pages 2638-2640

  Landmesser, Ulf ^a   Harrison, David G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; NITRIC OXIDE;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; EDITORIAL; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0035960605     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/circ.104.22.2638     Document Type: Editorial

References (24)

1. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
2. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
3. Prognostic significance of endothelial dysfunction in hypertensive patients
4. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
5. Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin
6. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits
7. The effect of cholesterollowering and antioxidant therapy on endothelium-dependent coronary vasomotion
8. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
9. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
10. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability
11. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease
12. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability
13. Vitamin E supplementation and cardiovascular events in high-risk patients: The heart outcomes prevention evaluation study investigators
14. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E,after myocardial infarction: Results of the GISSI-prevenzione trial
15. Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
16. Rates of interactions of superoxide with vitamin E, vitamin C and related compounds as measured by chemiluminescence
17. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases
18. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
19. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
20. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production
21. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: Involvement of angiotensin ATI receptor expression and Racl GTPase
22. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
23. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
24. Increased NADH-oxidasemediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system